Equity Holdings of Tata India Pharma & Healthcare Fund
Here is the most recent list of
equity holdings in the Tata India Pharma & Healthcare Fund's portfolio
as of 28 Feb 2025 . The fund's AUM is 842.81 crores, of which equity holdings constitute 98.05%.
Name of the Equity | Holding Percentage |
---|---|
SUN PHARMACEUTICAL INDUSTRIES LTD. | 11.61% |
AUROBINDO PHARMA LTD. | 7.10% |
CIPLA LTD. | 6.25% |
LUPIN LTD. | 6.22% |
DIVI'S LABORATORIES LTD. | 5.21% |
FORTIS HEALTHCARE LTD. | 4.75% |
APOLLO HOSPITALS ENTERPRISE LTD. | 3.98% |
Zydus Lifesciences Ltd | 3.74% |
Aster DM Healthcare Ltd | 3.31% |
Alkem Laboratories Ltd | 3.17% |
WOCKHARDT LTD. | 2.88% |
HealthCare Global Enterprises Ltd | 2.57% |
Laurus Labs Ltd | 2.41% |
AJANTA PHARMA LTD. | 2.13% |
TORRENT PHARMACEUTICALS LTD. | 1.89% |
IPCA LABORATORIES LTD. | 1.75% |
FDC LTD. | 1.63% |
Orchid Pharma Ltd | 1.52% |
Dr. Lal PathLabs Ltd | 1.46% |
INDOCO REMEDIES LTD. | 1.19% |
Metropolis Healthcare Ltd | 1.11% |
Piramal Pharma Ltd | 1.03% |
Ami Organics Ltd | 0.98% |
COROMANDEL INTERNATIONAL LTD. | 0.91% |
Sanofi India Ltd | 0.87% |
Medplus Health Services Ltd | 0.77% |
Procter & Gamble Health Ltd | 0.73% |
Syngene International Ltd | 0.63% |
GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 0.55% |
DEEPAK NITRITE LTD. | 0.30% |